Koichi Nakao Selected Research

Hypertension (High Blood Pressure)

5/2014	Clinical features and prognosis of patients with coronary spasm-induced non-ST-segment elevation acute coronary syndrome.
11/2010	Lack of effect of oral beta-blocker therapy at discharge on long-term clinical outcomes of ST-segment elevation acute myocardial infarction after primary percutaneous coronary intervention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Koichi Nakao Research Topics

Disease

43	Myocardial Infarction 02/2022 - 10/2004
19	Hemorrhage 05/2022 - 07/2016
17	Thrombosis (Thrombus) 01/2022 - 07/2010
15	Stroke (Strokes) 06/2022 - 04/2011
13	Acute Coronary Syndrome 01/2022 - 01/2012
10	ST Elevation Myocardial Infarction 01/2022 - 11/2010
9	Heart Failure 01/2022 - 01/2013
7	Unstable Angina 01/2021 - 06/2003
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 07/2013
6	Death (Near-Death Experience) 06/2022 - 03/2016
6	Non-ST Elevated Myocardial Infarction 01/2022 - 01/2015
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2016
5	Atrial Fibrillation 05/2022 - 01/2019
5	Atherosclerotic Plaque (Atheroma) 02/2021 - 08/2015
4	Chronic Renal Insufficiency 01/2021 - 01/2015
4	Infarction (Infarctions) 09/2018 - 11/2010
3	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 12/2017
3	Body Weight (Weight, Body) 02/2021 - 01/2017
3	Diabetes Mellitus 02/2021 - 04/2011
3	Reperfusion Injury 04/2016 - 01/2014
3	Spasm (Spasms) 05/2014 - 08/2005
2	Heart Arrest (Cardiac Arrest) 06/2022 - 01/2013
2	Ischemic Stroke 06/2022 - 01/2015
2	Tachycardia (Tachyarrhythmias) 01/2022 - 01/2019
2	Cardiogenic Shock 01/2022 - 04/2018
2	Rupture 10/2018 - 12/2017
2	Type 2 Diabetes Mellitus (MODY) 09/2018 - 01/2017
2	Pathologic Constriction (Stenosis) 01/2018 - 10/2010
2	Myocardial Ischemia (Ischemic Heart Diseases) 02/2016 - 01/2013
2	Hypertension (High Blood Pressure) 05/2014 - 11/2010
2	Coronary Vasospasm (Coronary Artery Vasospasm) 01/2011 - 08/2005
1	Cerebral Infarction 06/2022
1	Hemolysis 06/2022
1	Acute Kidney Injury (Acute Renal Failure) 06/2022
1	Sinus Tachycardia 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Aortic Dissection 01/2022
1	Peripheral Arterial Disease 10/2021
1	Anemia 10/2021
1	AIDS-Related Complex (ARC) 02/2021
1	Bradycardia 01/2019
1	Hemorrhagic Stroke 01/2019

Drug/Important Bio-Agent (IBA)

9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2021 - 10/2004
8	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 01/2022 - 09/2012
7	omega-Chloroacetophenone (Mace)IBA 10/2021 - 03/2016
6	Ezetimibe (Zetia)FDA Link 02/2021 - 08/2015
5	Clopidogrel (Plavix)FDA Link 01/2022 - 06/2003
5	TroponinIBA 01/2021 - 01/2015
5	Creatine Kinase (Creatine Phosphokinase)IBA 09/2020 - 01/2015
4	Prasugrel Hydrochloride FDA Link 05/2022 - 01/2021
4	Atorvastatin (Lipitor)FDA Link 02/2021 - 08/2015
4	LDL CholesterolIBA 01/2018 - 10/2015
4	oxidized low density lipoproteinIBA 01/2018 - 10/2015
4	Sirolimus (Rapamycin)FDA Link 07/2013 - 11/2010
3	LipidsIBA 10/2018 - 08/2015
3	Sodium-Hydrogen ExchangersIBA 04/2016 - 01/2014
3	3- guanidinocarbonyl- 2- methyl- 6,7,8,9- tetrahydro- 5H- cyclohepta(b)pyridine- 9- ylmethyl sulfuric acidIBA 04/2016 - 01/2014
3	Biomarkers (Surrogate Marker)IBA 01/2015 - 01/2010
2	Indicators and Reagents (Reagents)IBA 06/2022 - 09/2020
2	AnticoagulantsIBA 05/2022 - 02/2021
2	Matrix Metalloproteinases (MMPs)IBA 02/2022 - 10/2018
2	Rosuvastatin Calcium (Crestor)FDA Link 02/2022 - 10/2018
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2017
2	MetalsIBA 01/2022 - 04/2018
2	CholesterolIBA 02/2021 - 01/2018
2	C-Reactive ProteinIBA 07/2020 - 08/2005
2	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 04/2011
2	candesartanIBA 04/2016 - 01/2013
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2015 - 01/2011
2	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2008 - 08/2005
1	IceIBA 04/2022
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022
1	IvabradineIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2020
1	Phosphotransferases (Kinase)IBA 08/2020
1	CreatinineIBA 08/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2020
1	pimobendanIBA 01/2020
1	Everolimus FDA Link 01/2020
1	CobaltIBA 01/2020
1	ChromiumIBA 01/2020
1	APTIBA 01/2019
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	Dabigatran FDA Link 01/2019
1	Pioglitazone (Actos)FDA Link 09/2018
1	Eicosapentaenoic AcidIBA 05/2018

Therapy/Procedure

33	Percutaneous Coronary Intervention 06/2022 - 06/2003
25	Stents 06/2022 - 07/2010
25	Therapeutics 06/2022 - 10/2004
11	Drug-Eluting Stents 01/2022 - 01/2013
4	Transcatheter Aortic Valve Replacement 01/2022 - 12/2017
3	Secondary Prevention 10/2021 - 09/2018
3	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2017 - 10/2010
2	Catheters 04/2013 - 10/2010
2	Thrombectomy 04/2013 - 12/2009
1	Blood Transfusion (Blood Transfusions) 06/2022
1	Extracorporeal Membrane Oxygenation 06/2022
1	Cardiopulmonary Resuscitation (CPR) 06/2022
1	Patient Readmission 01/2020